Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1.1B | $1.2B | $306.9M | $314M | |
| Gross Profit | $499.9M | $475.5M | $503.4M | $142.9M | $130.3M | |
| Operating Income | -$11.5M | $5.5M | $6.2M | $13.8M | $1.4M | |
| EBITDA | $155.9M | $95.2M | $92.8M | $36M | $23.2M | |
| Diluted EPS | -$0.45 | $0.26 | $0.04 | $0.34 | -$0.05 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $780.7M | $881.8M | $927.6M | $815.5M | $669.3M | |
| Total Assets | $2.1B | $2.2B | $2.2B | $2.1B | $2B | |
| Current Liabilities | $876.2M | $428.4M | $367.8M | $595.7M | $476.6M | |
| Total Liabilities | $995.8M | $1.1B | $1B | $877.6M | $742.9M | |
| Total Equity | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | |
| Total Debt | $528.1M | $606M | $603.6M | $371.8M | $192.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $181.1M | $187.7M | $127.3M | $56.3M | $30.4M | |
| Cash From Investing | -$55M | -$52.8M | -$60.4M | -$13.6M | -$14.4M | |
| Cash From Financing | $23.4M | -$235.6M | -$218.3M | -$234.4M | $9.1M | |
| Free Cash Flow | $126.1M | $134.9M | $66.9M | $42.7M | $15.9M | |
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.
In the current month, OMCL has received 6 Buy ratings 1 Hold ratings, and 0 Sell ratings. The OMCL average analyst price target in the past 3 months is $57.43.
According to analysts, the consensus estimate is that Omnicell, Inc. share price will rise to $57.43 per share over the next 12 months.
Analysts are divided on their view about Omnicell, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Omnicell, Inc. is a Sell and believe this share price will drop from its current level to $49.00.
The price target for Omnicell, Inc. over the next 1-year time period is forecast to be $57.43 according to 7 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
According to Wall Street analysts, the consensus rating for Omnicell, Inc. is a Buy. 6 of 7 analysts rate the stock a Buy at this time.
You can purchase shares of Omnicell, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Omnicell, Inc. shares.
Omnicell, Inc. was last trading at $34.01 per share. This represents the most recent stock quote for Omnicell, Inc.. Yesterday, Omnicell, Inc. closed at $34.29 per share.
In order to purchase Omnicell, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Since January 28th, software stocks in the United States have…
Over the last five days, shares of Instagram and Facebook…
Market Cap: $4.4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 29x
Market Cap: $3.7T
P/E Ratio: 29x
National Storage Affiliates Trust [NSA] is down 3.88% over the past day.
Citi Trends, Inc. [CTRN] is up 11.52% over the past day.
Elbit Systems Ltd. [ESLT] is up 8.99% over the past day.